Ngā hua rapu - Provan, Sella A
- E whakaatu ana i te 1 - 11 hua o te 11
-
1
The changing states of fibromyalgia in patients with axial spondyloarthritis: results from the British Society of Rheumatology Biologics Register for Ankylosing Spondylitis mā Provan, Sella A, Dean, Linda E, Jones, Gareth T, Macfarlane, Gary J
I whakaputaina 2021Text -
2
Fatigue is cross-sectionally not associated with objective assessments of inflammation, but changes in fatigue are associated with changes of disease activity assessments during bi... mā Hammer, Hilde Berner, Michelsen, Brigitte, Sexton, Joe, Uhlig, Till, Provan, Sella A.
I whakaputaina 2020Text -
3
The association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis: a 10-year longitudinal study mā Provan, Sella A, Angel, Kristin, Ødegård, Sigrid, Mowinckel, Petter, Atar, Dan, Kvien, Tore K
I whakaputaina 2008Text -
4
Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study mā Angel, Kristin, Provan, Sella A., Fagerhol, Magne K., Mowinckel, Petter, Kvien, Tore K., Atar, Dan
I whakaputaina 2012Text -
5
Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumour necrosis factor inhibitors: data from register linkage of the NOR-DMARD study mā Christensen, Ingrid Egeland, Lillegraven, Siri, Mielnik, Pawel, Bakland, Gunnstein, Loli, Liz, Sexton, Joe, Uhlig, Till, Kvien, Tore K, Provan, Sella A
I whakaputaina 2022Text -
6
Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries mā Delcoigne, Benedicte, Ljung, Lotta, Provan, Sella A, Glintborg, Bente, Hetland, Merete Lund, Grøn, Kathrine Lederballe, Peltomaa, Ritva, Relas, Heikki, Turesson, Carl, Gudbjornsson, Bjorn, Michelsen, Brigitte, Askling, Johan
I whakaputaina 2022Text -
7
Associations between APOE Genotypes and Disease Susceptibility, Joint Damage and Lipid Levels in Patients with Rheumatoid Arthritis mā Maehlen, Marthe T., Provan, Sella A., de Rooy, Diederik P. C., van der Helm - van Mil, Annette H. M., Krabben, Annemarie, Saxne, Tore, Lindqvist, Elisabet, Semb, Anne Grete, Uhlig, Till, van der Heijde, Désirée, Mero, Inger Lise, Olsen, Inge C., Kvien, Tore K., Lie, Benedicte A.
I whakaputaina 2013Text -
8
Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example mā Chatzidionysiou, Katerina, Hetland, Merete Lund, Frisell, Thomas, Di Giuseppe, Daniela, Hellgren, Karin, Glintborg, Bente, Nordström, Dan, Aaltonen, Kalle, Törmänen, Minna RK, Klami Kristianslund, Eirik, Kvien, Tore K, Provan, Sella A, Guðbjörnsson, Bjorn, Dreyer, Lene, Kristensen, Lars Erik, Jørgensen, Tanja Schjødt, Jacobsson, Lennart, Askling, Johan
I whakaputaina 2018Text -
9
Immunogenicity and Safety of Standard and Third‐Dose SARS–CoV‐2 Vaccination in Patients Receiving Immunosuppressive Therapy mā Syversen, Silje W., Jyssum, Ingrid, Tveter, Anne T., Tran, Trung T., Sexton, Joseph, Provan, Sella A., Mjaaland, Siri, Warren, David J., Kvien, Tore K., Grødeland, Gunnveig, Nissen‐Meyer, Lise S. H., Ricanek, Petr, Chopra, Adity, Andersson, Ane M., Kro, Grete B., Jahnsen, Jørgen, Munthe, Ludvig A., Haavardsholm, Espen A., Vaage, John T., Lund‐Johansen, Fridtjof, Jørgensen, Kristin K., Goll, Guro L.
I whakaputaina 2022Text -
10
Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study mā Jyssum, Ingrid, Kared, Hassen, Tran, Trung T, Tveter, Anne T, Provan, Sella A, Sexton, Joseph, Jørgensen, Kristin K, Jahnsen, Jørgen, Kro, Grete B, Warren, David J, Vaage, Eline B, Kvien, Tore K, Nissen-Meyer, Lise-Sofie H, Anderson, Ane Marie, Grødeland, Gunnveig, Haavardsholm, Espen A, Vaage, John Torgils, Mjaaland, Siri, Syversen, Silje Watterdal, Lund-Johansen, Fridtjof, Munthe, Ludvig A, Goll, Guro Løvik
I whakaputaina 2022Text -
11
Sa1052: IMMUNOGENICITY AND SAFETY OF STANDARD AND THIRD DOSE SARS-COV-2 VACCINATION IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES; A PROSPECTIVE COHORT STUDY mā Joergensen, Kristin K., Syversen, Silje W, Jyssum, ingrid, Tveter, Anne Therese, Tran, Trung T., Sexton, Joe, Provan, Sella A., Mjaaland, Siri, Warren, David J., Kvien, Tore K., Gr⊘deland, Gunnveig, Nissen-Meyer, Lise Sofie H., Ricanek, Petr, Chopra, Adity, Anderson, Ane M., Kro, Grete B., Munthe, Ludvig A., Haavardsholm, Espen A., Vaage, John T.T., Lund-Johansen, Fridtjof, Jahnsen, Jorgen, Goll, Guro L.
I whakaputaina 2022Text